Pretreatment Quality of Life As a Predictor of Distant Metastasis and Survival for Patients With Nasopharyngeal Carcinoma
- 1 October 2010
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 28 (28) , 4384-4389
Abstract
Purpose: The purpose of this study was to examine the prognostic value of pretreatment quality of life (QoL) data on locoregional control (LRC), distant metastasis-free survival (DMFS), and overall survival (OS) in patients with nasopharyngeal carcinoma (NPC). Patients and Methods: A total of 347 new patients with NPC, who were curatively treated by conformal radiotherapy from March 2003 to December 2007, were recruited. The Taiwan Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 was completed before treatment. Multivariate Cox's proportional hazards models were used to analyze the impact of clinical and QoL variables on the treatment results. Results: The 5-year LRC, DMFS, and OS rates were 72.9%, 79.1%, and 68.4%, respectively. After adjusting the clinical variables, 10 QoL variables were observed to be significantly (P < .05) related to OS, and four QoL variables were related to DMFS. No QoL variable was predictive of LRC. Among the QoL variables that significantly predicted OS and DMFS, physical functioning was the most powerful predictor. A 10-point increase in the physical functioning score was associated with a 23% (95% CI, 12% to 34%) reduction in the likelihood of death and a 22% (95% CI, 9% to 36%) reduction in the likelihood of distant metastasis. Conclusion: Our findings indicate that pretreatment QoL variables, especially physical functioning, provide easily available prognostic value for distant metastasis and survival in patients with NPC.Keywords
This publication has 28 references indexed in Scilit:
- Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225Journal of Clinical Oncology, 2009
- Advances in nasopharyngeal carcinomaCurrent Opinion in Oncology, 2008
- Health-Related Quality of Life Parameters As Prognostic Factors in a Nonmetastatic Breast Cancer Population: An International Multicenter StudyJournal of Clinical Oncology, 2004
- Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Sociodemographic factors and quality of life as prognostic indicators in head and neck cancerEuropean Journal of Cancer, 2001
- The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapyRadiotherapy and Oncology, 2000
- Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancyEuropean Journal of Cancer, 1997
- Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survivalRadiotherapy and Oncology, 1997
- The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992